schizophrenia

News and resources

Apr 02 2026

Alto Neuroscience Misses Primary Endpoint in Schizophrenia Drug Study

by Clinical Editor

No Comments

Alto Neuroscience missed the primary endpoint for a study of its ALTO-101 drug for the treatment of cognitive impairment associated with schizophrenia.

Apr 02 2026

4 Ways to Find the Support You Need While Caring for a Person With Schizophrenia

by Clinical Editor

No Comments

Caring for a friend or loved one with schizophrenia can often feel all-consuming. You may find yourself sacrificing work, school, or downtime during moments of crisis. Remaining hours, meanwhile, are...

Apr 01 2026

Knowledge and Awareness of Reproductive Rights Among Women With Schizophrenia and Bipolar Affective Disorder – Cureus

by Clinical Editor

No Comments

Knowledge and Awareness of Reproductive Rights Among Women With Schizophrenia and Bipolar Affective Disorder Cureus

Apr 01 2026

A poorly “cleaned” brain can lead to schizophrenia

by Clinical Editor

No Comments

How can we explain the onset of psychotic symptoms characteristic of schizophrenia? Despite their major and often irreversible impact on intellectual abilities and autonomy, the biological …

Mar 31 2026

Would Earlier Initiation of Clozapine Improve First Episode Psychosis Outcomes?

by Clinical Editor

No Comments

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Mar 31 2026

Why this Stanford psychiatrist thinks diet can influence serious mental health disorders

by Clinical Editor

No Comments

Shebani Sethi is at the vanguard of metabolic psychiatry, a field that investigates the link between diet and serious mental health disorders.

Mar 30 2026

Would Earlier Initiation of Clozapine Improve FEP Outcomes? – Medscape

by Clinical Editor

No Comments

Would Earlier Initiation of Clozapine Improve FEP Outcomes? Medscape

Mar 29 2026

Health Rounds: Researchers find biomarker that could lead to improved schizophrenia treatments – Reuters

by Clinical Editor

No Comments

Health Rounds: Researchers find biomarker that could lead to improved schizophrenia treatments Reuters

Mar 29 2026

The direct and indirect costs of schizophrenia cause a sizable societal burden. – Psychology Today

by Clinical Editor

No Comments

The direct and indirect costs of schizophrenia cause a sizable societal burden. Psychology Today

Mar 29 2026

Phase 2 Trial of LB-102 for Schizophrenia Shows Positive Impact on Cognitive Performance – Psychiatric Times

by Clinical Editor

No Comments

Phase 2 Trial of LB-102 for Schizophrenia Shows Positive Impact on Cognitive Performance Psychiatric Times